Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Enhancement of axonal potassium conductance reduces nerve hyperexcitability in an in vitro model of oxaliplatin-induced acute neuropathy.
New Drugs Online report for idebenone
Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine.
Development of interferon beta-neutralising antibodies in multiple sclerosis-a systematic review and meta-analysis.
Changes of serum sICAM-1 and MMP-9 induced by rIFNbeta-1b treatment in relapsing-remitting MS.
The interaction of Q analogs, particularly hydroxydecyl benzoquinone (idebenone), with the respiratory complexes of heart mitochondria.
Glatiramer acetate exposure in pregnancy: preliminary safety and birth outcomes.
Rituximab product approval information - Licensing action
Interferon-beta in pediatric multiple sclerosis patients: safety in short-term prescription.
Serum from interferon-β-1b-treated patients with early multiple sclerosis stabilizes the blood-brain barrier in vitro.
Santhera and NIH collaborate to evaluate Catena® in primary progressive multiple sclerosis
Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled study.
Integrated genomic and prospective clinical studies show the importance of modular pleiotropy for disease susceptibility, diagnosis and treatment.
Effect of Glatiramer Acetate on Peripheral Blood Brain-Derived Neurotrophic Factor and Phosphorylated TrkB Levels in Relapsing-Remitting Multiple Sclerosis.
Clinically feasible MTR is sensitive to cortical demyelination in MS.
Thrombotic microangiopathy associated with use of interferon-beta.
Use of amiloride and multiple sclerosis: registry-based cohort studies.
Complex antibody profiling to predict clinical outcome in childhood ADS.
Zebrafish myelination: a transparent model for remyelination?
Gastrointestinal Tolerability of Delayed-Release Dimethyl Fumarate in a Multicenter, Open-Label Study of Patients with Relapsing Forms of Multiple Sclerosis (MANAGE).
Lithium Controls Central Nervous System Autoimmunity through Modulation of IFN-γ Signaling.
Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone.
Minocycline added to subcutaneous interferon β-1a in multiple sclerosis: randomized RECYCLINE study.
Control of oxidative stress and inflammation in sickle cell disease with the Nrf2 activator dimethyl fumarate.
Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy.

Pages